The legacy of the blue pill offers a complicated case study for investors eyeing the pharmaceutical sector. While first sales were remarkable, recent patent expiration and the emergence of alternative versions have https://inesdxfi532944.losblogos.com/39804184/sildenafil-and-pharma-a-precarious-investment